JPS5141663B1 - - Google Patents

Info

Publication number
JPS5141663B1
JPS5141663B1 JP41015472A JP1547266A JPS5141663B1 JP S5141663 B1 JPS5141663 B1 JP S5141663B1 JP 41015472 A JP41015472 A JP 41015472A JP 1547266 A JP1547266 A JP 1547266A JP S5141663 B1 JPS5141663 B1 JP S5141663B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP41015472A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP41015472A priority Critical patent/JPS5141663B1/ja
Priority to US622071A priority patent/US3535289A/en
Publication of JPS5141663B1 publication Critical patent/JPS5141663B1/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/02—Polycondensates containing more than one epoxy group per molecule
    • C08G59/12—Polycondensates containing more than one epoxy group per molecule of polycarboxylic acids with epihalohydrins or precursors thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/20—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the epoxy compounds used
    • C08G59/22—Di-epoxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Epoxy Resins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
JP41015472A 1966-03-12 1966-03-12 Pending JPS5141663B1 (OSRAM)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP41015472A JPS5141663B1 (OSRAM) 1966-03-12 1966-03-12
US622071A US3535289A (en) 1966-03-12 1967-03-10 Epoxy resin composition and its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP41015472A JPS5141663B1 (OSRAM) 1966-03-12 1966-03-12

Publications (1)

Publication Number Publication Date
JPS5141663B1 true JPS5141663B1 (OSRAM) 1976-11-11

Family

ID=11889725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP41015472A Pending JPS5141663B1 (OSRAM) 1966-03-12 1966-03-12

Country Status (2)

Country Link
US (1) US3535289A (OSRAM)
JP (1) JPS5141663B1 (OSRAM)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1458121A (en) * 1974-02-04 1976-12-08 Shell Int Research Epoxy resin composition
US4127695A (en) * 1975-10-07 1978-11-28 Matsushita Electric Industrial Co., Ltd. Method of insulating electromagnetic coils
US4444671A (en) * 1976-03-29 1984-04-24 S&C Electric Company Arc extinguishing material
US4760296A (en) * 1979-07-30 1988-07-26 General Electric Company Corona-resistant insulation, electrical conductors covered therewith and dynamoelectric machines and transformers incorporating components of such insulated conductors
EP0415879A3 (en) * 1989-08-23 1991-03-27 Ciba-Geigy Ag Carboxyl group ended polyhydroxy ester and its use
US20050079361A1 (en) * 2003-10-14 2005-04-14 Hamed Othman A. Materials useful in making cellulosic acquisition fibers in sheet form
CN100563718C (zh) * 2003-12-22 2009-12-02 伯拉考开发股份有限公司 用于反差成像的充气微囊组件
EP1912679A4 (en) * 2005-06-15 2009-07-29 Massachusetts Inst Technology AMINOUS LIPIDS AND ITS USES
WO2010053572A2 (en) 2008-11-07 2010-05-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
RS58405B1 (sr) 2009-12-01 2019-04-30 Translate Bio Inc Stereoidni derivati za isporuku irnk u humanim genetskim oboljenjima
US9193827B2 (en) 2010-08-26 2015-11-24 Massachusetts Institute Of Technology Poly(beta-amino alcohols), their preparation, and uses thereof
CA2831392C (en) 2011-03-28 2020-04-28 Massachusetts Institute Of Technology Conjugated lipomers and uses thereof
JP6184945B2 (ja) 2011-06-08 2017-08-23 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド ｍＲＮＡ送達のための脂質ナノ粒子組成物および方法
US20150267192A1 (en) 2012-06-08 2015-09-24 Shire Human Genetic Therapies, Inc. Nuclease resistant polynucleotides and uses thereof
WO2014028487A1 (en) 2012-08-13 2014-02-20 Massachusetts Institute Of Technology Amine-containing lipidoids and uses thereof
WO2014153052A2 (en) 2013-03-14 2014-09-25 Shire Human Genetic Therapies, Inc. Cftr mrna compositions and related methods and uses
EP2970955B1 (en) 2013-03-14 2018-11-14 Translate Bio, Inc. Methods for purification of messenger rna
US9315472B2 (en) 2013-05-01 2016-04-19 Massachusetts Institute Of Technology 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
BR112016009014B1 (pt) 2013-10-22 2024-02-06 Translate Bio, Inc USO DE COMPOSIÇÃO COMPREENDENDO mRNA PARA DEFICIÊNCIA DE ARGININOSSUCINATO SINTETASE
CN112656954A (zh) 2013-10-22 2021-04-16 夏尔人类遗传性治疗公司 用于递送信使rna的脂质制剂
MX2016005239A (es) 2013-10-22 2016-08-12 Shire Human Genetic Therapies Tratamiento con acido ribonucleico mensajero para la fenilcetonuria.
SG11201608725YA (en) 2014-04-25 2016-11-29 Shire Human Genetic Therapies Methods for purification of messenger rna
EP3587409B8 (en) 2014-05-30 2022-07-13 Translate Bio, Inc. Biodegradable lipids for delivery of nucleic acids
KR102511554B1 (ko) 2014-06-24 2023-03-16 샤이어 휴먼 지네틱 테라피즈 인크. 핵산의 전달용 입체화학적으로 풍부한 조성물
WO2016004202A1 (en) 2014-07-02 2016-01-07 Massachusetts Institute Of Technology Polyamine-fatty acid derived lipidoids and uses thereof
AU2018224326B2 (en) 2017-02-27 2024-01-04 Translate Bio, Inc. Novel codon-optimized CFTR mRNA
IL270631B2 (en) 2017-05-16 2024-03-01 Translate Bio Inc Treatment of cystic fibrosis through the administration of mRNA with an optimal codon encoding ctfr
CN112930396B (zh) 2018-08-24 2024-05-24 川斯勒佰尔公司 用于纯化信使rna的方法
US20200157157A1 (en) 2018-11-21 2020-05-21 Translate Bio, Inc. TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE620538A (OSRAM) * 1961-07-24
US3281376A (en) * 1961-12-29 1966-10-25 Union Carbide Corp Epoxide compositions containing a catalytic amount of a stannic organophosphate
BE632074A (OSRAM) * 1962-05-11
US3373221A (en) * 1964-11-04 1968-03-12 Shell Oil Co Reaction products of unsaturated esters of polyepoxides and unsaturated carboxylic acids, and polyisocyanates

Also Published As

Publication number Publication date
US3535289A (en) 1970-10-20

Similar Documents

Publication Publication Date Title
JPS5141663B1 (OSRAM)
AT281852B (OSRAM)
AU5917865A (OSRAM)
AU1534566A (OSRAM)
AU1141566A (OSRAM)
AU433222B2 (OSRAM)
AU417216B2 (OSRAM)
AU414526B2 (OSRAM)
AU421822B2 (OSRAM)
AU415165B1 (OSRAM)
AU1111066A (OSRAM)
AU6703465A (OSRAM)
AU612166A (OSRAM)
AU218666A (OSRAM)
AU5895065A (OSRAM)
AU1144366A (OSRAM)
BE689201A (OSRAM)
AU407778B2 (OSRAM)
BE675173A (OSRAM)
BE676560A (OSRAM)
BE682218A (OSRAM)
BE685167A (OSRAM)
AU411645B2 (OSRAM)
BE691953A (OSRAM)
BE692506A (OSRAM)